Valeant Reports 2nd Quarter Loss

Valeant Pharmaceuticals, parent company of Bausch + Lomb, is reporting 2nd quarter numbers that show a net loss of $302 million and sales of $2.4...
Original Story: 
Published Date: 
Tue, 08/09/2016 - 7:09am
»